UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 578

Sortiert nach

Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review

Clinical pharmacokinetics, 2019-10, Vol.58 (10), p.1265-1279

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis

Journal of clinical pharmacology, 2016-05, Vol.56 (5), p.628-636

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects

British journal of clinical pharmacology, 2013-11, Vol.76 (5), p.776-786

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

British journal of clinical pharmacology, 2013-12, Vol.76 (6), p.908-916

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban

Journal of clinical pharmacology, 2016-05, Vol.56 (5), p.637-645

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

British journal of clinical pharmacology, 2015-05, Vol.79 (5), p.838-846

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2014-04, Vol.14 (2), p.147-154

2014

Link zum Volltext

Verfügbarkeit prüfen

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban

Clinical pharmacology: advances and applications, 2014-01, Vol.6 (default), p.179-187

2014

Link zum Volltext

Verfügbarkeit prüfen

Overview of the Clinical Pharmacology of Ertugliflozin, a Novel Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor

Clinical pharmacokinetics, 2020-08, Vol.59 (8), p.949-965

2020

Link zum Volltext

Verfügbarkeit prüfen

Exploring Ireland's Viking-Age Towns: Houses and Homes

Boyd, Rebecca

1st, 2024

Link zum Volltext

Verfügbarkeit prüfen

Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016-04, Vol.16 (2), p.119-127

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers

Journal of clinical pharmacology, 2010-08, Vol.50 (8), p.941-950

2010

Link zum Volltext

Verfügbarkeit prüfen

Latin students’ bottom-up and top-down strategies for reading Latin literature and the impact of cross-linguistic influence

Journal of Latin linguistics, 2018-11, Vol.17 (2), p.301-332

Boyd, Rebecca M.

2018

Link zum Volltext

Verfügbarkeit prüfen

Heritage, Diaspora and the Consumption of Culture: Movements in Irish Landscapes

1, 2014

Link zum Volltext

Verfügbarkeit prüfen

The contribution of apixaban renal clearance to total clearance

Journal of thrombosis and thrombolysis, 2015-11, Vol.40 (4), p.521-522

2015

Link zum Volltext

Verfügbarkeit prüfen

Response to Letter to the Editor From Drs. Stöllberger and Finsterer: Original Publication: “Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, and Safety of Apixaban”

Journal of clinical pharmacology, 2016-05, Vol.56 (5), p.648-649

2016

Link zum Volltext

Verfügbarkeit prüfen

Response to Letter to the Editor From Drs. Stöllberger and Finsterer

Journal of clinical pharmacology, 2016-05, Vol.56 (5), p.648-649

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety, pharmacokinetics, and pharmacodynamics of PD 0348292, an oral, direct factor Xa inhibitor, after single and multiple dosings in healthy subjects

Clinical pharmacology in drug development, 2016-01, Vol.5 (1), p.13-26

2016

Link zum Volltext

Verfügbarkeit prüfen

Fall Injuries in Older Adults from an Unusual Source: Entering and Exiting a Vehicle

Journal of the American Geriatrics Society (JAGS), 2008-04, Vol.56 (4), p.609-614

2008

Link zum Volltext

Verfügbarkeit prüfen

Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Clinical pharmacology: advances and applications, 2013-01, Vol.5 (Issue 1), p.59-66

2013

Link zum Volltext

Verfügbarkeit prüfen

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]

Clinical pharmacology: advances and applications, 2018-01, Vol.10, p.71-72

2018

Link zum Volltext

Verfügbarkeit prüfen

Seasonal regulation of the growth hormone-insulin-like growth factor-I axis in the American black bear (Ursus americanus)

American journal of physiology: endocrinology and metabolism, 2011-10, Vol.301 (4), p.E628-E636

2011

Link zum Volltext

Verfügbarkeit prüfen

Falls and fear of falling: burden, beliefs and behaviours

Age and ageing, 2009-07, Vol.38 (4), p.423-428

2009

Link zum Volltext

Verfügbarkeit prüfen

The pharmacokinetics of PF‐734200, a DPP‐IV inhibitor, in subjects with renal insufficiency

British journal of clinical pharmacology, 2011-07, Vol.72 (1), p.85-91

2011

Link zum Volltext

Verfügbarkeit prüfen

Low Self-control and Deviance: Examining the Moderation of Social Support from Parents

Deviant behavior, 2008-05, Vol.29 (4), p.388-410

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 578

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(485)
Mit Volltextzugriff
(499)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(346)
Life Sciences & Biomedicine
(314)
Humans
(227)
Female
(126)
Male
(105)
Adult
(81)
Middle Aged
(59)
Animals
(55)
Social Sciences
(53)
Biological And Medical Sciences
(41)
Pharmacology & Pharmacy
(40)
Aged
(37)
Public, Environmental & Occupational Health
(37)
Adolescent
(36)
Medical Sciences
(34)
Child
(32)
Young Adult
(28)
General & Internal Medicine
(27)
Public Health
(26)
Risk Factors
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban

Overview of the Clinical Pharmacology of Ertugliflozin, a Novel Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor

Exploring Ireland's Viking-Age Towns: Houses and Homes

Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa

Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers

Latin students’ bottom-up and top-down strategies for reading Latin literature and the impact of cross-linguistic influence

Heritage, Diaspora and the Consumption of Culture: Movements in Irish Landscapes

The contribution of apixaban renal clearance to total clearance

Response to Letter to the Editor From Drs. Stöllberger and Finsterer: Original Publication: “Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, and Safety of Apixaban”

Response to Letter to the Editor From Drs. Stöllberger and Finsterer

Safety, pharmacokinetics, and pharmacodynamics of PD 0348292, an oral, direct factor Xa inhibitor, after single and multiple dosings in healthy subjects

Fall Injuries in Older Adults from an Unusual Source: Entering and Exiting a Vehicle

Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]

Seasonal regulation of the growth hormone-insulin-like growth factor-I axis in the American black bear (Ursus americanus)

Falls and fear of falling: burden, beliefs and behaviours

The pharmacokinetics of PF‐734200, a DPP‐IV inhibitor, in subjects with renal insufficiency

Low Self-control and Deviance: Examining the Moderation of Social Support from Parents

Suchergebnisse filtern